Matches in Wikidata for { <http://www.wikidata.org/entity/Q93180675> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q93180675 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q93180675 description "scientific article published on 17 October 2019" @default.
- Q93180675 description "wetenschappelijk artikel" @default.
- Q93180675 description "наукова стаття, опублікована 17 жовтня 2019" @default.
- Q93180675 name "Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?" @default.
- Q93180675 name "Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?" @default.
- Q93180675 type Item @default.
- Q93180675 label "Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?" @default.
- Q93180675 label "Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?" @default.
- Q93180675 prefLabel "Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?" @default.
- Q93180675 prefLabel "Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?" @default.
- Q93180675 P1433 Q93180675-EC29A1C1-99F4-455A-8FF0-751CCBB50EF7 @default.
- Q93180675 P1476 Q93180675-7834CCEE-EBE1-43B0-AB07-7A63AF2D3AF3 @default.
- Q93180675 P2093 Q93180675-3720A0EF-9FF4-4EA9-9D69-AB289EF96B36 @default.
- Q93180675 P2093 Q93180675-668721EC-6183-4054-B45A-07052C85113D @default.
- Q93180675 P2093 Q93180675-A0DAFAC2-2469-4391-A0F1-A84D324378A6 @default.
- Q93180675 P2093 Q93180675-C19CDFB5-DCAF-4B75-B19A-43C6E8BD78DD @default.
- Q93180675 P2093 Q93180675-C963AABF-A92C-472F-B59F-86472061E3CB @default.
- Q93180675 P304 Q93180675-CF1AD152-BBB8-42EF-989F-43A55C4A4824 @default.
- Q93180675 P31 Q93180675-E7D8D990-6789-4660-B301-01B90E0D4021 @default.
- Q93180675 P31 Q93180675-a9e4c27a-b895-472a-855f-32d6588578c7 @default.
- Q93180675 P356 Q93180675-149435EE-A15B-40A0-AC36-FA4E6B59ECEF @default.
- Q93180675 P433 Q93180675-F24E0D90-CE0C-4C7C-9D76-47D3AE2A30B5 @default.
- Q93180675 P478 Q93180675-7DD32B0F-E339-409A-9DEB-337171E5C9A2 @default.
- Q93180675 P50 Q93180675-41F3FEA5-CE10-4DE8-BB65-E034E6C1FA82 @default.
- Q93180675 P577 Q93180675-585C8C73-7C86-4614-B433-134654399CB1 @default.
- Q93180675 P698 Q93180675-C32C4697-093C-411F-99C7-366845D02E21 @default.
- Q93180675 P921 Q93180675-3726BE70-BA95-4E93-BFBE-B5C014E7A755 @default.
- Q93180675 P921 Q93180675-4769B1D9-CC8B-436A-94DB-F36C100BB706 @default.
- Q93180675 P356 DOM.13881 @default.
- Q93180675 P698 31495989 @default.
- Q93180675 P1433 Q5270109 @default.
- Q93180675 P1476 "Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?" @default.
- Q93180675 P2093 "Antonio Ceriello" @default.
- Q93180675 P2093 "Francesco Cosentino" @default.
- Q93180675 P2093 "Katherine Esposito" @default.
- Q93180675 P2093 "Luca De Nicola" @default.
- Q93180675 P2093 "Pasquale Perrone-Filardi" @default.
- Q93180675 P304 "149-157" @default.
- Q93180675 P31 Q13442814 @default.
- Q93180675 P31 Q7318358 @default.
- Q93180675 P356 "10.1111/DOM.13881" @default.
- Q93180675 P433 "2" @default.
- Q93180675 P478 "22" @default.
- Q93180675 P50 Q59197360 @default.
- Q93180675 P577 "2019-10-17T00:00:00Z" @default.
- Q93180675 P698 "31495989" @default.
- Q93180675 P921 Q271993 @default.
- Q93180675 P921 Q3025883 @default.